Simcere granted Chinese approval for generic Biapenem injection

Novosom obtains patents for Smarticles

Germany based Novosom has received patents for both the US and Europe for its drug Delivery technology Smarticles.

AstraZeneca wins approval for bipolar disorder drug

AstraZeneca has announced that the FDA has approved Seroquel for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.

Nestle and GE collaborate in health and nutrition diagnostics

The Nestle Research Center, Lausanne, Switzerland and GE Global Research, the General Electric Company's centralized research and development organization, have announced an innovative collaboration to scientifically assess associations between body composition, metabolic status, diet and lifestyle habits.

Oncolytics to initiate Phase II trial of intravenous cancer therapy

Oncolytics Biotech has received a letter of approval from the UK Medicines and Healthcare products Regulatory Agency, for its clinical trial application to begin a Phase II clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers.

StemCor wins grant for bone marrow harvesting device

StemCor Systems has received a National Institutes of Health Phase I Small Business Innovation Research Grant to further develop the MarrowMiner, which recently received 510(k) clearance from the FDA for harvesting bone marrow.

Qiagen and Geneart join hands to commercialize synthetic genes

Qiagen and Geneart have announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins.

AVI BioPharma's antisense drugs found effective against lethal virus

AVI BioPharma has announced that treatment of non-human primates with either the antisense drug AVI-6002 or with the antisense drug AVI-6003, resulted in a reproducible and high rate of survival in the face of an otherwise lethal infection with Ebola or Marburg virus, respectively.

Lundbeck introduces insomnia drug in Europe

Lundbeck has launched Circadin, a new, first in class sleep medication for insomnia sufferers in Europe.

St Jude Medical initiates cardiac therapy study

St Jude Medical has announced the initial enrollments into a new landmark clinical trial designed to better identify which patients could benefit from implantable cardioverter defibrillator therapy for the prevention of sudden cardiac arrest.

Medimetriks launches operations

Medimetriks Pharmaceuticals has commenced operations. The newly-formed company will develop, license and commercialize innovative prescription products for the dermatology and podiatry marketplaces.

Xtent announces positive results from drug eluting stent safety trial

Xtent has announced positive six-month follow-up data from the Custom III clinical trial, which assessed the safety and efficacy of the Custom NX drug eluting stent system for the treatment of patients with coronary artery disease.

Browse by Industry Biotech Biotechnology Drug Delivery Drug Discovery Drug Manufacturing Drugs Manufacturing Pharmaceutical Manufacturers Pharmaceutical Manufacturing Healthcare Healthcare Services Medical Devices Medical Devices and Diagnostics OTC (Over-the-Counter) OTC Drugs Manufacturing Over-the-Counter Healthcare (OTC) Over-the-Counter Medicines (OTC) Other Pharmaceuticals Therapeutic Areas Therapy Area Browse by Name #0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Company List Top 10 Global Pharmaceuticals Companies Top 30 Global Chemicals Companies